Conmed Corp (CNMD) Q3 2025 Earnings Call Highlights: Strong Sales Growth Amidst Margin Challenges [Yahoo! Finance]
CONMED Corporation (CNMD)
Last conmed corporation earnings: 4/29 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
conmed.com/en/about-us/investors/investor-relations
Company Research
Source: Yahoo! Finance
Adjusted Net Income: $33.4 million, up 2.2% year over year. Adjusted Diluted Earnings Per Share: $1.08, an increase of 2.9% compared to the prior year quarter. Orthopedic Sales Growth: 5.3% globally in constant currency. General Surgery Sales Growth: 6.9% globally in constant currency. Adjusted Gross Margin: 56.1%, a 40 basis point decline compared to Q3 of 2024. Research and Development Expense: 4.1% of sales, 20 basis points lower than the prior year quarter. Adjusted SGA Expenses: 37.3% of sales, 10 basis points higher than the prior year. Adjusted Interest Expense: $6.3 million in the third quarter. Adjusted Effective Tax Rate: Cash Flow from Operations: $53.7 million compared to $51.2 million in the third quarter of 2024. Capital Expenditures: $5.2 million compared to $3.4 million a year ago. Long-term Debt: $853.0 million at the end of the quarter. Leverage Ratio: 3.0 times as of September 30th. Q4 Revenue Guidance: Between $363 and $370 million. Ful
Show less
Read more
Impact Snapshot
Event Time:
CNMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CNMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CNMD alerts
High impacting CONMED Corporation news events
Weekly update
A roundup of the hottest topics
CNMD
News
- CONMED Corporation Announces Strategic Exit from Gastroenterology Product LinesBusiness Wire
- CONMED (NYSE:CNMD) had its price target lowered by analysts at JPMorgan Chase & Co. from $58.00 to $52.00. They now have a "neutral" rating on the stock.MarketBeat
- CONMED (NYSE:CNMD) had its price target lowered by analysts at Piper Sandler from $68.00 to $55.00. They now have an "overweight" rating on the stock.MarketBeat
- CONMED (NYSE:CNMD) had its price target lowered by analysts at Wells Fargo & Company from $57.00 to $47.00. They now have an "equal weight" rating on the stock.MarketBeat
- CONMED Corporation Announces Third Quarter 2025 Financial ResultsBusiness Wire
CNMD
Earnings
- 11/5/25 - Beat
CNMD
Sec Filings
- 12/5/25 - Form 8-K
- 11/24/25 - Form 4
- 11/21/25 - Form 4
- CNMD's page on the SEC website